Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer.
Dathathri E, Isebia KT, Abali F, Lolkema MP, Martens JWM, Terstappen LWMM, Bansal R. Dathathri E, et al. Among authors: bansal r. Front Oncol. 2022 May 20;12:863472. doi: 10.3389/fonc.2022.863472. eCollection 2022. Front Oncol. 2022. PMID: 35669415 Free PMC article. Review.
TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo.
Akcora BÖ, Dathathri E, Ortiz-Perez A, Gabriël AV, Storm G, Prakash J, Bansal R. Akcora BÖ, et al. Among authors: bansal r. FASEB J. 2019 Aug;33(8):9466-9475. doi: 10.1096/fj.201900215RR. Epub 2019 May 17. FASEB J. 2019. PMID: 31100032
O., Dathathri, E., Ortiz-Perez, A., Gabriel, A. V., Storm, G., Prakash, J., Bansal, R. TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo....
O., Dathathri, E., Ortiz-Perez, A., Gabriel, A. V., Storm, G., Prakash, J., Bansal, R. TG101348, a selective JAK2 antagonist, …
Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.
Isebia KT, Dathathri E, Verschoor N, Nanou A, De Jong AC, Coumans FAW, Terstappen LWMM, Kraan J, Martens JWM, Bansal R, Lolkema MP. Isebia KT, et al. Among authors: bansal r. Cancers (Basel). 2022 Sep 10;14(18):4404. doi: 10.3390/cancers14184404. Cancers (Basel). 2022. PMID: 36139564 Free PMC article.
Innate Immunity and Pathogenesis of Biliary Atresia.
Ortiz-Perez A, Donnelly B, Temple H, Tiao G, Bansal R, Mohanty SK. Ortiz-Perez A, et al. Among authors: bansal r. Front Immunol. 2020 Feb 25;11:329. doi: 10.3389/fimmu.2020.00329. eCollection 2020. Front Immunol. 2020. PMID: 32161597 Free PMC article. Review.
Editorial: Macrophages in Liver Disease.
Bansal R, Mandrekar P, Mohanty SK, Weiskirchen R. Bansal R, et al. Front Immunol. 2020 Aug 4;11:1754. doi: 10.3389/fimmu.2020.01754. eCollection 2020. Front Immunol. 2020. PMID: 32849626 Free PMC article. No abstract available.
Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K, Bansal R, Storm G, Prakash J. Binnemars-Postma K, et al. Among authors: bansal r. FASEB J. 2018 Feb;32(2):969-978. doi: 10.1096/fj.201700629R. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29066614
In summary, inhibition of the Stat6 pathway in TAMs is a vital therapeutic approach to attenuate tumor growth and metastasis by inhibiting TAM-induced protumorigenic and prometastatic activities.-Binnemars-Postma, K., Bansal, R., Storm, G., Prakash, J. Targeting the …
In summary, inhibition of the Stat6 pathway in TAMs is a vital therapeutic approach to attenuate tumor growth and metastasis by inhibiting T …
1,691 results